Therefore, SHP2 hyperactivity in oral cancer cells might result from the inappropriate expression of SHP2 binding protein, which causes the aberrant activation of SHP2 [33,34]. The gene discussed is PTPN11; the disease is lip and oral cavity carcinoma.